Novel DMT Compound For Anxiety Shows Clinical Progress: Robust Effects Within 2 Minutes
Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released
Could DMT Therapy Be The Future Of Brain Injury Treatment? This Study Has Promising Results
Intravenous DMT Therapy Seeks Ideal Dosage For Stroke And TBI Treatment
DMT Entities Recent News
Small Pharma Inc: Positive Clinical Data For Major Depressive Disorder, Upcoming Virtual Roundtable
Development Of DMT Transdermal Patch With Eye Disease Treatment In Mind
Developing Psychedelic Treatments For Traumatic Brain Injury: Algernon Launches New Program
Algernon Touts Positive Study Findings, Confirms Next Trial Phase With Escalated Dose
Short-Acting Psychedelics: DMT-Based Drug Therapy Gets Tested In New Clinical Trial
Cybin Reports Q3 Earnings, Says Psilocybin Tial Is Progressing As MDD Treatment
Race Is On For Psychedelic DMT-Related Compounds, Small Pharma, Inc To Issue Two New Patents
Small Pharma, Inc's Psychedelics For Major Depression Trial Results And Q1 Earnings
Psychedelics Companies Join The Race To Develop Much-Needed Anxiety Treatment
Encountering DMT Entities: Are They Real?